Cardiotoxicity and the 10-year cardiovascular risk profiles of breast cancer patients in a resource-poor setting
The gains made with treating breast cancer patients are threatened by the emergence of cardiovascular disease (CVD) as a significant driver of mortality in this population, either directly from the use of cardiotoxic agents or the increasing prevalence of CVD risk factors. Though there are validated tools for ass...